Tezacaftor
Back to searchMolecule Structure
Scientific Name
Tezacaftor
Description of the Drug
Tezacaftor is a medication used to treat homozygous or heterozygous F508del mutation cystic fibrosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11712
http://www.drugbank.ca/drugs/DB11712
Brand Name(s)
Not Available
Company Owner(s)
Vertex Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Cystic fibrosis transmembrane conductance regulator | SINGLE PROTEIN | POSITIVE MODULATOR | CHEMBL4051 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL322362 |
| Human Metabolome Database | HMDB0304895 |
| DrugBank | DB11712 |
| PubChem: Thomson Pharma | 96053596 |
| PubChem | 46199646 |
| LINCS | LSM-45570 |
| PDBe | CV6 |
| BindingDB | 281054 |
| EPA CompTox Dashboard | DTXSID40673070 |
| DrugCentral | 5276 |
| ChemicalBook | CB22632076 |
| Guide to Pharmacology | 10199 |
| rxnorm | TEZACAFTOR |
| ZINC | ZINC000068206930 |
